Stacey Waddington
Physician Assistant · Shelbyville, ILNPI 1154578615
Payments from drug & device makers
Across 123 payments — averaging $15.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$328
- Novo Nordisk$299
- Novartis$261
- Amgen$247
- Lilly USA, LLC$173
- AstraZeneca$127
- plus $515 from 17 others
What the payments were for
- Food & beverage$1,950100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 19 | $328 |
| Novo Nordisk | 24 | $299 |
| Novartis | 14 | $261 |
| Amgen | 15 | $247 |
| Lilly USA, LLC | 11 | $173 |
| AstraZeneca | 9 | $127 |
| Boehringer Ingelheim | 5 | $97 |
| Exact Sciences | 3 | $59 |
| Otsuka America Pharmaceutical, Inc. | 3 | $51 |
| Johnson & Johnson | 3 | $42 |
| E.r. Squibb & Sons, L.L.C. | 3 | $42 |
| Lundbeck LLC | 2 | $34 |
| Astellas Pharma US Inc | 2 | $27 |
| Boston Scientific | 1 | $26 |
| Corcept Therapeutics | 1 | $17 |
| Merck | 1 | $17 |
| Bayer | 1 | $17 |
| Dexcom, Inc. | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| GSK | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $14 |
| Pfizer | 1 | $12 |
| Mylan Specialty L.p. | 1 | $12 |
How this compares
$1,950 in reported general payments places this provider in the 80th percentile of 3,912 physician assistant providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 24 | $24,032 |
| MounjaroTirzepatide | 18 | $18,791 |
| Breo ElliptaFluticasone/Vilanterol | 22 | $10,200 |
| TrulicityDulaglutide | 11 | $9,573 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 27 | $713 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 11 | $621 |
| Lisinopril | 83 | $340 |
| Levothyroxine Sodium | 46 | $301 |
| Ketoconazole | 13 | $296 |
| Gabapentin | 26 | $264 |
| Escitalopram Oxalate | 23 | $258 |
| Potassium Chloride | 21 | $256 |
| Pantoprazole Sodium | 42 | $252 |
| Metoprolol Succinate | 48 | $243 |
| Quetiapine Fumarate | 23 | $236 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $173 | $28,36329 claims |
| Novo NordiskOzempic | $299 | $24,03224 claims |
| GSKBreo Ellipta | $14 | $10,20022 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,912 physician assistant providers in Illinois.
Other physician assistant in Shelbyville
- Andrew MastroChicago$419K
- Christopher AricoSkokie$407K
- Karlijn BurridgeWestmont$144K
- Ian MackeySkokie$135K
- Stephanie TraceyItasca$122K
- Olabimpe PhilipsAddison$103K
- Renata BlockChicago$103K
- Margaret RomanoChicago$82K
- Christina StarksChicago$77K
- Darrel CutlerHerrin$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.